| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Anti-inhibitor coagulant complex |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Microfibrillar collagen hemostat (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Absorbable gelatin film |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Absorbable gelatin powder |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Eptacog alfa (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Thrombin agent |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Factor IX complex |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Aminocaproic acid |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Human antihemophilic plasma |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Carbazochrome salicylate |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Plasma substitutes (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulant (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Antihemophilic factor agent (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Local application of hemostyptics onto gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Injektionsbehandling af duodenallæsion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Local application of haemostyptics onto duodenal lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| hæmostatisk middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Haemostatic adverse reaction |
Causative agent |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Ethamsylate adverse reaction |
Causative agent |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Collagen adverse reaction |
Causative agent |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| allergi over for hæmostatikum |
Causative agent |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to etamsylate |
Causative agent |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Allergy to collagen (finding) |
Causative agent |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Endoscopic application of hemostyptics to gastric lesion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
2 |
| Injektion til hæmostase af duodenallæsion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Injektion til hæmostase af gastrisk morfologisk forandring i |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Adrenalininjektion til hæmostase af gastrisk morfologisk forandring i |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
2 |
| Adrenalininjektion til hæmostase af duodenallæsion |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Endoscopic injection haemostasis of duodenal ulcer |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| Endoscopic injection haemostasis of gastric ulcer |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Fibrinolytic drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Antifibrinolytic drugs and hemostatics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing etamsylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| etamsylat 250 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Etamsylate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Collagen [hemostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing human fibrinogen and thrombin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 10 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| desmopressinacetat 100 µg/1 ml opløsning til intranasal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| desmopressinacetat 4 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Succinyleret gelatine 4 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing collagen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Application of chemical hemostatic agents (procedure) |
Direct substance |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
1 |
| faktor IX-kompleks 100 % pulver til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 1.5mg/mL spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| antihæmofilifaktor 500 enheder/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| desmopressinacetat 0,01 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Desmopressin acetate 0.01% spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Tranexamic acid (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Aprotinin (substance) |
Is a |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Tissue factor, the high-affinity receptor and cofactor for the plasma serine protease VII/VIIa |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Etamsylate (substance) |
Is a |
True |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| desmopressinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing antihemophilic factor agent (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing desmopressin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VIII-fraktion-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor IX-fraktion-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor IX 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor VIIa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 60.000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 120.000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| rekombinant koagulationsfaktor VIIa 240.000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulation factor VIII- and von Willebrand factor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VIII 500 IE/von Willebrand-faktor 1100 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VIII 1000 IE/von Willebrand-faktor 2200 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor XIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor XIII 250 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor XIII 1250 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Acset |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| intermediat faktor IX |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing anti-inhibitor coagulant complex (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor IX-koncentrat-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor V-koncentrat-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VII-koncentrat-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| DNA-faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| intermediat faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing porcine factor VIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Coagulation factor II- and coagulation factor IX- and coagulation factor VIIa- and coagulation factor VIII- and coagulation factor X-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing coagulation factor XI (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| Product containing von Willebrand factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| tørret og varmebehandlet faktor IX-fraktion 600 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VIII-bypassing-fraktion 500 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| faktor VIII-bypassing fraktion 1000 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor VIII-fraktion 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| intermediat faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| intermediat faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| porcin faktor VIII 700 IE, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor IX 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor IX 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
| højrenset faktor IX 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hemostatic agent (substance) |
Inferred relationship |
Some |
|
FHIR